Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 6 Squamous Cell Carcinoma of Head and Neck 2 Obesity 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Diseases 1 Insulin Resistance 1 Inflammation 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Diabetes Mellitus 1 Barrett Esophagus 1

Interventions

montelukast 1 Tablets 1 Spironolactone 1 Pioglitazone 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Inflammation × Metformin × Clear all

NCT02689843 2019-11-12

AntiPCO

Shiraz University of Medical Sciences

Phase EARLY_PHASE1 Completed

Inflammation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡